Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

MNPRMNPR
5 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in MONOPAR THERAPEUTICS INC

Bank of New York Mellon Corp holds 76,942 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $7.1M as of 2026-Q2. The position was decreased (-2.1% shares). MNPR represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$7.1M

Current Shares

76,942

Total Value Change

+$6.8M

Total Shares Change

+67,994

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
76,942
-2.1%
$7.1M0.0%$92.59
0
2026-Q1
Increased
78,618
+21.2%
$4.3M0.0%$51.88
32
2025-Q4
Increased
64,857
+277.7%
$4.2M0.0%$65.07
43
2025-Q3
Increased
17,170
+91.9%
$1.4M0.0%$75.90
40
2025-Q2
New
8,948
-
$320,1530.0%$33.60
33

Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used